About Us
The Project

Sponsored by the Innovative Medicines Initiative (IMI) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) under the Horizon 2020 programme, PharmaLedger is a 36 month project that brings together 12 global pharmaceutical companies and 17 public and private entities; including technical, legal, regulatory, academia, research organisations and patient representative organisations.

Objectives

The goal of the project is to provide a widely trusted platform that supports the design and adoption of blockchain-enabled healthcare solutions while accelerating delivery of innovation that benefits the entire ecosystem, from manufacturers to patients.

Develop a scalable, sustainable, beyond-state-of-the-art blockchain platform

Define and formalise an effective governance for the PharmaLedger framework

Ensure privacy and confidentiality of PharmaLedger data

Perform reference implementation and validation of prioritised business use cases

Develop and integrate a health data marketplace and a collaboration platform

Allow greater access to and security of information across use cases that integrate the use of IOT and medical devices.

Provide a legal and ethical framework to ensure regulatory, legal and data privacy compliance

Involve key healthcare ecosystem stakeholders in the elicitation of requirements and testing of the reference implementation

Generate a comprehensive industry digitisation methodology and document it in a manual for small, medium and large industry players and provide a set of new patients’ engagement processes for supply and consumption of health data

Road map

Jan 2020

Yr1: Design & Foundations

Jan 2021

Yr2: Development & Deployment

Jan 2022

Yr3: Validation & Sustainability

Dec 2022

Project Organization

  • EU & EFPIA
    (Innovative Medicine Initiative)
  • External Expert Advisory Board
  • Ethics Board
  • Project Management Board (WP7)

    Project Leader: (NVS)
    Coordinator: (UPM)

Steering Committee
(Project Management Board + WP Leaders + Scientific & Technical Managers)
  • (WP1)
    Business Use-Case

    (MSD & UPM)

  • (WP2)
    Implementation & Solutions

    (ABBV & PDM)

  • (WP3)
    Architecture & Reference Implementation

    (NVS & RMS)

  • (WP4)
    Governance

    (PFZ & AVO)

  • (WP5)
    Regulatory, Legal and Data Privacy

    (NOVO & KUL)

  • (WP6)
    Culture & Adoption

    (NVS & TVS)

  • (WP1)
    Business Use-Case

    (MSD & UPM)

  • DRA 1 (Supply Chain)

    (J&J, Bayer & PDM)

    DRA 2 (Health Data)

    (UCB & UPM)

    DRA 3 (Clinical Trial)

    (UCB & ONO, OPBG)

  • (WP2)
    Implementation & Solutions

    (ABBV & PDM)

  • (WP3)
    Architecture & Reference Implementation

    (NVS & RMS)

  • Scientific Manager

    (CERTH)

  • Technical Manager

    (NVS & RMS)

  • (WP4)
    Governance

    (PFZ & AVO)

  • (WP5)
    Regulatory, Legal and Data Privacy

    (NOVO & KUL)

  • Ethical / Legal Manager

    (NOVO & KUL)

  • (WP6)
    Culture & Adoption

    (NVS & TVS)

  • Dissemination & Communication Manager

    (TVS)

  • Sustainability & Innovation Manager

    (PFZ)

  • DRA 1 (Supply Chain)

    (J&J, Bayer & PDM)

    DRA 2 (Health Data)

    (UCB & UPM)

    DRA 3 (Clinical Trial)

    (UCB & ONO, OPBG)

  • Scientific Manager

    (CERTH)

  • Technical Manager

    (NVS & RMS)

  • Dissemination & Communication Manager

    (TVS)

  • Sustainability & Innovation Manager

    (PFZ)

  • Ethical / Legal Manager

    (NOVO & KUL)

General Assembly
One representative from each consortium member entity

Contact

Sign up to receive the latest information, news and activities regarding the PharmaLedger project.